Evidence map›Paper›PMID 36618811›Full record

ArticleAnnals of translational medicine2022

Medication reconciliation to support pharmacogenomics implementation.

Scott A Mosley, Joshua M Pevnick

Abstract readEditorial
In one paragraph

Article in Annals of translational medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Pre-emptive pharmacogenetic testing in the acute hospital setting: a cross-sectional study.QJM : monthly journal of the Association of Physicians · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Scott A MosleyDepartment of Clinical Pharmacy, University of Southern California (USC) School of Pharmacy, Los Angeles, CA, USA.
Joshua M PevnickDepartment of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Funding

Southern California Clinical and Translational Science InstituteUL1TR001855 · NCATS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Thomas A Buchanan, Michele D. Kipke · 2016 to 2026
$81.3M
Mentored Career DevelopmentKL2TR001854 · NCATS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Elizabeth Rhea Erwin Burner, Amy Elizabeth West · 2016 to 2026
$9.0M
Mitigating Benzodiazepine and Sedative Use in the Hospital through Inpatient DeprescribingR01AG058911 · NIA · CEDARS-SINAI MEDICAL CENTER · PI PEVNICK, JOSHUA M · 2018 to 2022
$4.0M
NCATS NIH HHS KL2 TR001854NCATS NIH HHS UL1 TR001855NIA NIH HHS R01 AG058911
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36618811
PMCPMC9816836

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.